vTv Therapeutics Inc (VTVT)

[Amatuer17]

An interesting milestone coming.
The 18 months for part A will finish in Mar and we can expect the topline results sometime in April.

This is one of the few (maybe only) P3 study ending for ALZ in 2018.
As usual chances of success are very low but this is a new approach not AMYLOID or BACE or TAU - it has something new.


“Enrollment of Part A was completed in September 2016 with data expected to read out in early 2018 Part B data is expected to read out in late 2018.”